Company Filing History:
Years Active: 2018
Title: Beth-Ann Coller: Pioneering Advances in West Nile Virus Vaccination
Introduction
Beth-Ann Coller is an innovative inventor based in West Point, Pennsylvania, recognized for her significant contributions to medical science. With a strong commitment to public health, she has focused her research on developing effective vaccines to combat infectious diseases.
Latest Patents
Coller holds a patent for a West Nile virus vaccine, which comprises the WN-80E recombinant subunit protein. This vaccine aims to provide a robust immune response and is designed for human use. It features a recombinantly produced form of truncated West Nile virus envelope glycoprotein, combined with an aluminum adjuvant, making it safe and effective for a wide range of populations, including immunosuppressed and immunocompromised individuals. The inclusion of a pharmaceutically acceptable vehicle ensures the vaccine's stability and efficacy in various health scenarios.
Career Highlights
Currently, Beth-Ann Coller is employed at Hawaii Biotech, Inc., where she collaborates with leading professionals in the field to further develop and promote her vaccine research. Her dedication to advancing vaccine technology plays a crucial role in fighting infectious diseases with significant public health implications.
Collaborations
Throughout her career, Coller has worked closely with talented colleagues, including Vidya Pai and Carolyn L Weeks-Levy. Together, they contribute to the innovative research environment at Hawaii Biotech, Inc., fostering collaboration and shared knowledge that propel advancements in vaccine development.
Conclusion
Beth-Ann Coller stands out as a vital figure in the landscape of medical innovation, particularly in the domain of vaccine development. Her work embodies a blend of scientific rigor and a deep understanding of public health needs, making her a key contributor in the fight against the West Nile virus and similar threats to global health.